SCHEMBL2247658

SCHEMBL2247658

C=CCCCCCCC(CCCC=C)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CYP2C19 P33261 1/20 0.37
TSHR P16473 1/20 0.34
HRH1 P35367 2/20 0.34
ABCC4 O15439 1/20 0.34
MAPT P10636 1/20 0.34
HTR2A P28223 1/20 0.34
CYP19A1 P11511 3/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HDAC1 Q13547 5/20 0.34
HDAC4 P56524 4/20 0.34
HDAC3 O15379 3/20 0.34
HDAC7 Q8WUI4 3/20 0.34
HDAC2 Q92769 3/20 0.34
HDAC10 Q969S8 3/20 0.34
HDAC11 Q96DB2 3/20 0.34
HDAC8 Q9BY41 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17183738 0.90 TSHR (0.42) USP2ALDH1A1HPGDTDP1CYP2C19
SCHEMBL17183688 0.90 TSHR (0.42) USP2ALDH1A1HPGDTDP1CYP2C19
SCHEMBL17183667 0.90 TSHR (0.47) ALDH1A1TSHRHTR2ASIGMAR1OPRD1
SCHEMBL17183752 0.90 TSHR (0.47) ALDH1A1TSHRHTR2ASIGMAR1OPRD1
SCHEMBL17183729 0.90 TSHR (0.42) USP2ALDH1A1HPGDTDP1CYP2C19
SCHEMBL17183699 0.90 TSHR (0.52) ALDH1A1TSHRHTR2ASIGMAR1OPRD1
SCHEMBL17183832 0.90 TSHR (0.52) ALDH1A1TSHRHTR2ASIGMAR1OPRD1
SCHEMBL17183679 0.90 TSHR (0.52) ALDH1A1TSHRHTR2ASIGMAR1OPRD1
SCHEMBL17183663 0.90 TSHR (0.47) USP2ALDH1A1HPGDTDP1CYP2C19
SCHEMBL17183631 0.90 TSHR (0.42) USP2ALDH1A1HPGDTDP1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110207977-A1 METHOD FOR PRODUCING A-OLEFIN OLIGOMER, A-OLEFIN OLIGOMER, AND LUBRICATING OIL COMPOSITION IDEMITSU KOSAN CO., LTD. (JP) 2011-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110207977-A1 METHOD FOR PRODUCING A-OLEFIN OLIGOMER, A-OLEFIN OLIGOMER, AND LUBRICATING OIL COMPOSITION MOGAT2, OSBP, OXER1 USP2 1830/4885ALDH1A1 2083/4885HPGD 880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.